Author:
Chung Sung-Hyun,Yook Juwon,Min Byung Jun,Lee Jae Yeol,Lee Yong Sup,Jin Changbae
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference21 articles.
1. Cheng, Y. C., and Prusoff, W. H., Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction,Biochem. Pharmacol., 22, 3099–3108 (1973).
2. Doxey, J. C., Smith, C. F. C., and Walker, J. M., Selectivity of blocking agents for pre- and postsynaptic a-adrenoceptors.Br. J. Pharmacol., 60, 91–96 (1977).
3. Giardina, W. J., Buckner, S. A., Hancock, A. A., Lee, J.-Y., Wismer, C. T., and DeBernadis, J. F., A-75169 HCl: Pharmacological profile and ocular pharmacology studies of a new α2 antagonist,Drug Development Res., 28, 56–64 (1993).
4. Glowinski, J., and Iverson, L. L., Regional studies of catecholamines in the rat brain: I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]DOPA in various regions of the brain,J. Neurochem., 13, 655–669 (1966).
5. Goldberg, M. R., and Robertson, D., Yohimbine: A pharmacological probe of the α2-adrenoceptor. Pharmacol. Rev., 35, 143–180 (1983).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献